Clopidogrel
Clopidogrel is an orally active platelet inhibitor that targets P2Y12 receptor. Clopidogrel is used to inhibit blood clots in coronary artery disease, peripheral vascular disease, and cerebrovascular disease.
Product Specifications
CAS Number
[113665-84-2]
Product Name Alternative
Clopidogrelum
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
P2Y Receptor
Type
Reference compound
Related Pathways
GPCR/G Protein
Applications
Neuroscience-Neuromodulation
Field of Research
Cardiovascular Disease; Cancer
Assay Protocol
https://www.medchemexpress.com/clopidogrel.html
Concentration
10mM
Purity
99.57
Solubility
DMSO : 50 mg/mL (ultrasonic)
Smiles
ClC1=C(C=CC=C1)[C@H](N2CCC3=C(C2)C=CS3)C(OC)=O
Molecular Formula
C16H16ClNO2S
Molecular Weight
321.82
Precautions
H302, H315, H319, H335
References & Citations
[1]Zongyu Zheng, et al. Clopidogrel Reduces Fibronectin Accumulation and Improves Diabetes-Induced Renal Fibrosis. Int J Biol Sci. 2019 Jan.|[2]An insight into the interaction between clopidogrel and proton pump inhibitors By Shah, Bhavik S.; Parmar, Sanjay A.; Mahajan, Shailaja; Mehta, Anita A. From Current Drug Metabolism (2012), 13 (2),225-235.
Shipping Conditions
Blue Ice
Storage Conditions
-20°C (Powder, stored under nitrogen, away from moisture)
Scientific Category
Reference compound1
Clinical Information
Launched
Isoform
P2Y12 Receptor
Citation 01
ACS Environ Au. 2025 Aug 8.|ACS Nano. 2023 Apr 11;17 (7) :6519-6533.|Biochem Pharmacol. 2025 Dec;242 (Pt 3) :117379.|Drug Des Devel Ther. 2020 Dec 21:14:5599-5610.|Front Pharmacol. 2022 Jan 10;12:792263.|Front Pharmacol. 2024 Oct 23:15:1496639.|Int J Biol Sci. 2019 Jan 1;15 (1) :239-252.|Int J Mol Med. 2025 May;55 (5) :78.|Int J Mol Sci. 2022 Aug 14;23 (16) :9118.|iScience. 2024 Feb 5;27 (3) :109134.|J Adv Res. 2024 Jul 5:S2090-1232 (24) 00269-8.|J Appl Physiol (1985) . 2021 Nov 1;131 (5) :1552-1564.|J Pharm Health Care Sci. 2021 May 4;7 (1) :18.|Open Chem. 2020 Jun.|Res Sq. 2023 Nov 14:rs.3.rs-3474507.|Theranostics. 2023 Mar 27;13 (6) :2040-2056.|Thromb J. 2024 Jul 10;22 (1) :59.|Thromb Res. 2023 Jul:227:17-24.|Thromb Res. 2024 Apr 16.|University of Colorado Denver. 2024.|ACS Omega. 2020 Aug 4;5 (32) :19995-20003.|Am J Transl Res. 2020 May 15;12 (5) :1741-1753.|Foods. 2023 Feb 10;12 (4) :777.|Front Pharmacol. 2021 Oct 8:12:734603.|J Ethnopharmacol. 2024 Aug 22:118707.|J Food Biochem. 2020 Sep;44 (9) :e13352.
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1310295-01 0.02 mg (E-Coli)
Recombinant Fowlpox virus Bcl-2-like protein FPV039 (FPV039)
Ask
View Details 
MBS1310295-02 0.1 mg (E-Coli)
Recombinant Fowlpox virus Bcl-2-like protein FPV039 (FPV039)
Ask
View Details MBS1310295-03 0.02 mg (Yeast)
Recombinant Fowlpox virus Bcl-2-like protein FPV039 (FPV039)
Ask
View Details